FGF‐23 is associated with cardiac troponin T and mortality in hemodialysis patients
FGF‐23 is associated with cardiac troponin T and mortality in hemodialysis patients
复制标题
FGF-23 与血液透析患者的心肌肌钙蛋白 T 和死亡率相关
DOI:
10.1111/j.1542-4758.2011.00630.x
复制
发表时间:
2011
影响因子:
1.3
通讯作者:
R. Foley
中科院分区:
文献类型:
--
作者:
R. Holden;David Beseau;S. Booth;Michael A. Adams;J. Garland;R. Morton;C. Collier;R. Foley
Fibroblast growth factor 23 (FGF‐23) is elevated in patients with end‐stage kidney disease and has been linked with mortality, vascular calcification, markers of bone turnover, and left ventricular hypertrophy. In this cohort study, we determined the correlates of FGF‐23 (including cardiac troponin T [cTNT]) and determined its association with mortality over 3.5 years of follow‐up in 103 prevalent hemodialysis patients. Mean age was 61.2 (15.5) and the mean dialysis vintage was 4.19 years (4.6). The median (interquartile range) FGF‐23 was 1259 (491, 2885) RU/mL. Independent predictors (estimate standard error) of log‐transformed FGF‐23 concentrations included phosphorus (0.75 [0.237], P = 0.002) and cardiac troponin T (1.04 [0.41], P = 0.01). There were 57 deaths. In the fully adjusted model, the significant predictors of mortality included age and albumin. The independent association between FGF‐23 and cTNT is a novel finding. Whether this relationship supports the possibility that a downstream effect of dysregulated phosphorous homeostasis may be enhanced cardiac remodeling requires further study.
影响因子:
20.1
作者:
S. Vatner
通讯作者:
S. Vatner
影响因子:
13.6
作者:
Slinin, Y;Foley, RN;Collins, AJ
通讯作者:
Collins, AJ
影响因子:
13.6
作者:
Gutierrez, O;Isakova, T;Wolf, M
通讯作者:
Wolf, M